|Description||4-Bromo-calcimycin, a halogenated analog of A-2318, is a non-Fluorescent Ca2+ ionophore which could be commonly used in fluorescent probes experiments as a modutor of the quantitation of free Ca2+.|
|Appearance||Slight yellow crystals|
|Synonyms||4-Bromo-A23187; 4-Bromocalcimycin; 4-Benzoxazolecarboxylic acid, 6-bromo-5-(methylamino)-2-(((2S,3S,6S,8S,9R,11R)-3,9,11-trimethyl-8-((1S)-1-methyl-2-oxo-2-(1H-pyrrol-2-yl)ethyl)-1,7-dioxaspiro(5.5)undec-2-yl)methyl)-|
|Solubility||DMSO, Methanol, Dichloromethane|
|Storage||Refrigerate upon arrival, at +2°C to +8°CUse the original container to store the product.Keep the lid tightly closed.Avoid exposing to strong direct light.May be kept deep frozen.|
|Application||Nonfluorescent calcium ionophore used as a calibration standard for determining cytoplasmic calcium ions by fluorescent probes.|
|Melting Point||205 °C-210 °C|
A semi–synthetic analogue of pleuromutilin; a potent and highly selective antibiotic active against a range of gram positive bacteria; inhibits protein synthesi...
A semi-synthetic macrocyclic lactone derived from erthyromycin; provides a broader spectrum of action, higher acid stability and improved bioavailability compar...
One of the new generation erythromycins introduced in the 1980s. Improved acid stability was achieved by converting the 9-keto group to the more stable oxime an...
A semi-synthetic antibiotic derived from a tylosin derivative; a wider spectrum of antibiotic action than the dibasic analogues such as tilmicosin, in particula...
A macrolide antibiotic active against a broad range of gram positive bacteria; enhance acid stability and improve oral bioavailability compared with erythromyci...
A degradation product of tetracycline, formed by dehydration at the C6 position under acidic conditions to aromatise the B ring; an important standard for monit...
An acid degradation product produced by selective hydrolysis of the more labile forosamine saccharide in the 17-position of 3-ethoxy-5,6-dihydrospinosyn J, the ...
An early semi-synthetic erythromycin, prepared by reaction of the 9-keto moiety to methyl oxime; shows broad spectrum antibacterial and antiprotozoan activity a...
The salt prepared from valnemulin; the preferred formulation for pharmaceutical applications; a broad spectrum antibiotic used to control gastrointestinal infec...
A salt of clindamycin, a semi-synthetic lincosamide; the hydrochloride salt forms at the basic N-ethylproline moiety and is the preferred pharmaceutical formula...
An acid degradation product produced by hydrolysis of the disaccharide unit of doramectin; an inhibitor of nematode larval development; devoid of paralytic acti...
A first generation cephalosporin antibiotic; slightly soluble in aqueous solution (1.789 mg/ml)
A degradation product of chlorotetracycline formed by acid-catalysed isomerisation of the dimethylamino group at C4; exhibits little antibiotic activity
Chloramphenicol succinate sodium
The salt prepared from chloramphenicol succinate using the free carboxylic acid of the succinate which ionises and readily forms in weakly sodium hydroxide solu...
17-AAG,an analog of geldanamycin, is a potent heat shock protein 90 (Hsp90) inhibitor (IC50= 5 nM) with a 100-fold higher binding affinity for HSP90 derived fro...
A degradation product of oxytetracycline, formed under acidic conditions. An initial dehydration to anhydrooxytetracycline then undergoes an internal cyclisatio...
Milbemycin A3 oxime
A semi-synthetic macrocyclic lactone prepared by the oxidation and oximation of a mixture of milbemycin A3; the minor component (~30%) in the commercial product...
A degradation product of chlorotetracycline formed by acid-catalysed isomerisation of the dimethylamino group at C4
An extended spectrum beta-lactam antibiotic; similar in structure to ampicillin; can be combined with clavulanate potassium for greater efficacy against beta-la...
The major component (>80%) of the commercial anthelmintic, ivermectin; exert their anthelmintic effects by binding to glutamate-gated chloride channels expresse...